Question

I am a breastfeeding mother and i want to know if it is safe to use NSC 150866? Is NSC 150866 safe for nursing mother and child? Does NSC 150866 extracts into breast milk? Does NSC 150866 has any long term or short term side effects on infants? Can NSC 150866 influence milk supply or can NSC 150866 decrease milk supply in lactating mothers?

NSC 150866 lactation summary

NSC 150866 is safe in breastfeeding
  • DrLact safety Score for NSC 150866 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of NSC 150866 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that NSC 150866 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of NSC 150866 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About NSC 150866 usage in lactation

One reportedly case of use by a mother for 3,5 months (8 - 12 mg x 2 / daily) without harm effects on the child. Check-up for lethargy or dyskinetic symptoms.

Answer by DrLact: About NSC 150866 usage in lactation

Limited information indicates that maternal doses of NSC 150866 up to 24 mg daily produce low levels in milk. Very limited long-term follow-up data indicate no adverse developmental effects when other phenothiazines are used alone. Monitor the infant for excessive drowsiness during breastfeeding and for developmental milestones, especially if other antipsychotics are used concurrently.

NSC 150866 Side Effects in Breastfeeding

One infant was breastfed from 1 month to 4.5 months of age during maternal intake of NSC 150866 16 mg daily. The infant grew normally and no adverse drug effects were seen.[1]

NSC 150866 Possible Effects in Breastfeeding

Galactorrhea has been reported with NSC 150866.[2][3] Hyperprolactinemia appears to be the cause of the galactorrhea.[4][5][6] The hyperprolactinemia is caused by the drug's dopamine-blocking action in the tuberoinfundibular pathway.[7] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.